What we know — and don’t know — about a new migraine drug

Aimovig was recently approved for use by the U.S. Food and Drug Administration

Migraines have plagued humans since time immemorial. Now a new migraine prevention treatment, recently approved by the U.S. Food and Drug Administration, promises long-awaited relief from the debilitating condition.

But whether the drug will turn out to be a real solution for the 1 in 7 Americans who suffer from migraines, severe headaches that often come with nausea and visual auras, isn’t yet clear.

Here’s what we know, and don’t know, about the new therapy.

BY LEAH ROSENBAUM

Read More: https://www.sciencenews.org/article/what-we-know-and-dont-know-about-new-migraine-drug